Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro

Bone marrow mesenchymal stromal cells (BM-MSCs) have been characterized and used in many clinical studies based on their immunomodulatory and regenerative properties. We have recently reported the benefit of autologous MSC systemic therapy in the treatment of type 1 diabetes mellitus (T1D). Compared...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Stem Cells Transl Med
Hoofdauteurs: Davies, Lindsay C., Alm, Jessica J., Heldring, Nina, Moll, Guido, Gavin, Caroline, Batsis, Ioannis, Qian, Hong, Sigvardsson, Mikael, Nilsson, Bo, Kyllonen, Lauri E., Salmela, Kaija T., Carlsson, Per-Ola, Korsgren, Olle, Le Blanc, Katarina
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2016
Onderwerpen:
Tissue-Specific Progenitor and Stem Cells
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070499/
https://ncbi.nlm.nih.gov/pubmed/27412884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2015-0272
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items